Omada Health adds connected blood pressure and blood sugar monitors to platform
The new devices are part and parcel with the programs launched by the company last year to help support the treatment of patients with hypertension and Type 2 diabetes.
The new devices are part and parcel with the programs launched by the company last year to help support the treatment of patients with hypertension and Type 2 diabetes.
The Wall Street Journal reports that Mountain View, California-based Livongo has enlisted Morgan Stanley, Goldman Sachs Group Inc. and JPMorgan Chase & Co. as underwriters for an IPO that would value the company in excess of $1 billion.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Burke joined the Mountain View, California-based chronic disease management company late last year after spending more than two decades at EHR giant Cerner.
Livongo has revealed a new voice-enabled blood pressure monitoring system, which is powered by Amazon Lex and Amazon Polly.
The startup previously developed the Sleepio application, which is targeted at insomnia, and is offered to around 12 million users through partnerships with payers and employers like Boston Medical Center, Comcast and the NHS.
The myStrength news comes fresh off the heels of competitor Omada Health's effort to add on similar services using technology developed by failed behavioral health startup Lantern.
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
New CFO Lee Shapiro has worked with Livongo Founder Glen Tullman for two decades, both at Allscripts and venture investing firm 7wire Ventures.
The new offerings are part of the company's evolution to what it calls Applied Health Signals, a shorthand to describe their platform's combination of data science and contextually relevant behavior change tools.
In 2018 alone, ten companies have inked mega-deals of more than $100 million including Livongo, 23andMe and American Well.
At the Health 2.0 conference in Santa Clara a range of healthcare players from large employers to young startups spoke about their approaches to developing and implementing digital therapeutics.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
Numerous emerging companies aim to fix America's broken healthcare system. How can we differentiate between solving the issue and contributing to the system's existing fragmentation?
The Chicago-based venture capital firm has closed its Connected Consumer Health Fund and has invested in twelve companies to date.
The Series E round, which was led by existing investors General Catalyst and Kinnevik, included participation from Merck Global Health Innovation Fund, Microsoft Ventures and others.
The roll out of Livongo's upgraded device follows the close of a $45 million Series C round earlier this year.